TransMedics (TMDX) Raw Materials (2018 - 2026)

TransMedics' Raw Materials history runs 9 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• On a quarterly basis, Raw Materials changed 0.07% year-over-year to $24.9 million in Q1 2026; TTM through Mar 2026 was $24.9 million, a 0.07% change from a year earlier, with the FY2025 full-year figure at $26.2 million, down 6.34% from the prior year.
• Raw Materials retreated to $24.9 million in Q1 2026 per TMDX's latest filing, from $26.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $28.0 million in Q3 2024 and bottomed at $8.3 million in Q1 2022.
• The 5-year median for Raw Materials is $20.3 million (2025), against an average of $19.7 million.
• Across the five-year window, Raw Materials soared 136.06% in 2023 and tumbled 30.35% in 2025, its largest moves.
• Year by year, Raw Materials stood at $10.9 million in 2022, then surged by 136.06% to $25.8 million in 2023, then climbed by 8.54% to $28.0 million in 2024, then decreased by 6.34% to $26.2 million in 2025, then slipped by 5.02% to $24.9 million in 2026.
• Per Business Quant, the three latest TMDX Raw Materials figures stand at $24.9 million (Q1 2026), $26.2 million (Q4 2025), and $20.3 million (Q3 2025).